{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:38:31Z","timestamp":1792607911377,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012025","name":"New York University Abu Dhabi","doi-asserted-by":"publisher","award":["AD055"],"award-info":[{"award-number":["AD055"]}],"id":[{"id":"10.13039\/100012025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jbc.2024.107821","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:21:57Z","timestamp":1727454117000},"page":"107821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals"],"prefix":"10.1016","volume":"300","author":[{"given":"Juliana C.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenana","family":"Al Adem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-8387","authenticated-orcid":false,"given":"Samar","family":"Fadl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Alzyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-8037","authenticated-orcid":false,"given":"Mohammad A.","family":"Ghattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael M.","family":"Rabeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107821_bib1","article-title":"Covid-19 and community mitigation strategies in a pandemic","volume":"368","author":"Ebrahim","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jbc.2024.107821_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","article-title":"The sars-cov-2 outbreak: what we know","volume":"94","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jbc.2024.107821_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-385885-6.00009-2","article-title":"Coronavirus pathogenesis","volume":"81","author":"Weiss","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jbc.2024.107821_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jbc.2024.107821_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107821_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (sars cov-2 or n-cov19), the cause of covid-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.jbc.2024.107821_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"Covid-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.jbc.2024.107821_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jbc.2024.107821_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/jcm9041131","article-title":"Pharmacological therapeutics targeting rna-dependent rna polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for covid-19","volume":"9","author":"Huang","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.jbc.2024.107821_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for covid-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between sars-cov-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2024.107821_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of sars-cov-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107821_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.jbc.2024.107821_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000507423","article-title":"Covid-19 outbreak: an overview","volume":"64","author":"Ciotti","year":"2019","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jbc.2024.107821_bib15","article-title":"Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options","volume":"58","author":"Khan","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.jbc.2024.107821_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of sars-cov-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107821_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for sars-cov-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107821_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/BCJ20200029","article-title":"Processing of the sars-cov pp1a\/ab nsp7-10 region","volume":"477","author":"Krichel","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107821_bib19","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A\u00a0noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks sars virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107821_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"Sars coronavirus papain-like protease inhibits the type i interferon signaling pathway through interaction with the sting-traf3-tbk1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.jbc.2024.107821_bib21","doi-asserted-by":"crossref","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of irf-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"Ikkepsilon and tbk1 are essential components of the irf3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.107821_bib23","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1073\/pnas.1710617115","article-title":"Irreversible inactivation of isg15 by a viral leader protease enables alternative infection detection strategies","volume":"115","author":"Swatek","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107821_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, plpro, of sars-cov-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107821_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BJ20141170","article-title":"Sars hcov papain-like protease is a unique lys48 linkage-specific di-distributive deubiquitinating enzyme","volume":"468","author":"B\u00e9k\u00e9s","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107821_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.molcel.2016.04.016","article-title":"Recognition of lys48-linked di-ubiquitin and deubiquitinating activities of the sars coronavirus papain-like protease","volume":"62","author":"B\u00e9k\u00e9s","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107821_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104641","article-title":"Structural and functional insights into non-structural proteins of coronaviruses","volume":"150","author":"Rohaim","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jbc.2024.107821_bib28","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1042\/BCJ20220380","article-title":"Therapeutic potential of metal ions for covid-19: insights from the papain-like protease of sars-cov-2","volume":"479","author":"Shetler","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107821_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107821_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The sars-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"Baez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jbc.2024.107821_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of sars-cov-2 papain-like protease","volume":"11","author":"Gao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jbc.2024.107821_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from sars-cov-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107821_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15181-y","article-title":"Inhibitor induced conformational changes in sars-cov-2 papain-like protease","volume":"12","author":"Ferreira","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107821_bib34","article-title":"Targeting sars-cov-2 proteases for covid-19 antiviral development","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib35","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","article-title":"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity","volume":"79","author":"Barretto","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107821_bib36","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107821_bib37","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.3390\/ijms23073711","article-title":"Host and viral zinc-finger proteins in covid-19","volume":"23","author":"Esposito","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.107821_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000115","article-title":"In silico drug repurposing for covid-19: targeting sars-cov-2 proteins through docking and consensus ranking","volume":"40","author":"Cavasotto","year":"2021","journal-title":"Mol. Inform."},{"key":"10.1016\/j.jbc.2024.107821_bib40","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1080\/07391102.2020.1784291","article-title":"Repurposing of fda-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against sars-cov-2 papain-like protease","volume":"39","author":"Kandeel","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbc.2024.107821_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpha.2021.09.001","article-title":"Drug repurposing against coronavirus disease 2019 (covid-19): a review","volume":"11","author":"Luo","year":"2021","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.jbc.2024.107821_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/2472555220963667","article-title":"High-throughput screening for drugs that inhibit papain-like protease in sars-cov-2","volume":"25","author":"Smith","year":"2020","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2024.107821_bib43","article-title":"Bispecific repurposed medicines targeting the viral and immunological arms of covid-19","volume":"11","author":"Redhead","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107821_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijbiomac.2021.07.184","article-title":"Repurposing clinically approved drugs for covid-19 treatment targeting sars-cov-2 papain-like protease","volume":"188","author":"Xu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jbc.2024.107821_bib45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00836-9","article-title":"High-throughput screening identifies established drugs as sars-cov-2 plpro inhibitors","volume":"12","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.jbc.2024.107821_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of sars-cov-2 plpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of m(pro) from sars-cov-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107821_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02680-20","article-title":"Hepatitis c virus protease inhibitors show differential efficacy and interactions with remdesivir for treatment of sars-cov-2 in\u00a0vitro","volume":"65","author":"Gammeltoft","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2024.107821_bib49","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1042\/BCJ20210244","article-title":"Identifying sars-cov-2 antiviral compounds by screening for small molecule inhibitors of nsp3 papain-like protease","volume":"478","author":"Lim","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107821_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.700703","article-title":"A\u00a0birds-eye (re)view of acid-suppression drugs, covid-19, and the highly variable literature","volume":"12","author":"Mura","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107821_bib51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/acsptsci.1c00240","article-title":"Validation and invalidation of sars-cov-2 papain-like protease inhibitors","volume":"5","author":"Ma","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib52","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/s41598-021-84782-w","article-title":"The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication","volume":"11","author":"Loffredo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107821_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/nar\/gkg161","article-title":"Structural classification of zinc fingers: survey and summary","volume":"31","author":"Krishna","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107821_bib54","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/D0SC02646H","article-title":"Multi-targeting of functional cysteines in multiple conserved sars-cov-2 domains by clinically safe zn-ejectors","volume":"11","author":"Sargsyan","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fmolb.2020.00174","article-title":"Insights into dynamics of inhibitor and ubiquitin-like protein binding in sars-cov-2 papain-like protease","volume":"7","author":"Bosken","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jbc.2024.107821_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2017.12.015","article-title":"Disulfiram can inhibit mers and sars coronavirus papain-like proteases via different modes","volume":"150","author":"Lin","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jbc.2024.107821_bib57","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/acsptsci.0c00130","article-title":"Ebselen, disulfiram, carmofur, px-12, tideglusib, and shikonin are nonspecific promiscuous sars-cov-2 main protease inhibitors","volume":"3","author":"Ma","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib58","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1080\/07391102.2020.1780946","article-title":"Chemical-informatics approach to covid-19 drug discovery: Monte Carlo based qsar, virtual screening and molecular docking study of some in-house molecules as papain-like protease (plpro) inhibitors","volume":"39","author":"Amin","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbc.2024.107821_bib59","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1080\/07391102.2020.1776639","article-title":"Virtual screening-driven drug discovery of sars-cov2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms","volume":"39","author":"Quimque","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbc.2024.107821_bib60","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1080\/07391102.2021.1897679","article-title":"Black tea bioactives as inhibitors of multiple targets of sars-cov-2 (3clpro, plpro and rdrp): a virtual screening and molecular dynamic simulation study","volume":"40","author":"Gogoi","year":"2022","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbc.2024.107821_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.822785","article-title":"Potential inhibitors targeting papain-like protease of sars-cov-2: two birds with one stone","volume":"10","author":"Jiang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib62","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of sars-cov-2 plpro inhibitors for covid-19 antiviral therapy leveraging binding cooperativity","volume":"65","author":"Shen","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib63","doi-asserted-by":"crossref","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound sars-cov-2 papain-like protease: a framework for anti-covid-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107821_bib64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s42003-022-03737-7","article-title":"Antiviral activity of natural phenolic compounds in complex at an allosteric site of sars-cov-2 papain-like protease","volume":"5","author":"Srinivasan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2024.107821_bib65","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of sars-cov-2 papain-like protease inhibitors through a combination of high-throughput screening and a flipgfp-based reporter assay","volume":"7","author":"Ma","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib66","doi-asserted-by":"crossref","first-page":"832431","DOI":"10.3389\/fchem.2022.832431","article-title":"Hydrazones and thiosemicarbazones targeting protein-protein-interactions of sars-cov-2 papain-like protease","volume":"10","author":"Ewert","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2024.107821_bib67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2024.107821_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jbc.2024.107821_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1423-0127-21-54","article-title":"Structural and functional characterization of mers coronavirus papain-like protease","volume":"21","author":"Lin","year":"2014","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.jbc.2024.107821_bib70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13205-017-0744-3","article-title":"Mers-cov papain-like protease (plpro): expression, purification, and spectroscopic\/thermodynamic characterization","volume":"7","author":"Malik","year":"2017","journal-title":"3 Biotech."},{"key":"10.1016\/j.jbc.2024.107821_bib71","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1021\/bi0504761","article-title":"Papain-like protease 2 (plp2) from severe acute respiratory syndrome coronavirus (sars-cov): expression, purification, characterization, and inhibition","volume":"44","author":"Han","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107821_bib72","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1128\/JVI.78.24.13600-13612.2004","article-title":"Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity","volume":"78","author":"Harcourt","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107821_bib73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of grl0617 and sars-cov-2 plpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107821_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004113","article-title":"Structural basis for the ubiquitin-linkage specificity and deisgylating activity of sars-cov papain-like protease","volume":"10","author":"Ratia","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107821_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-020-00335-z","article-title":"Sars-cov-2: the many pros of targeting plpro","volume":"5","author":"McClain","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2024.107821_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012100","article-title":"Deubiquitinating activity of sars-cov-2 papain-like protease does not influence virus replication or innate immune responses in\u00a0vivo","volume":"20","author":"van Huizen","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107821_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","article-title":"The outbreak of covid-19: an overview","volume":"83","author":"Wu","year":"2020","journal-title":"J.\u00a0Chin. Med. Assoc."},{"key":"10.1016\/j.jbc.2024.107821_bib78","doi-asserted-by":"crossref","DOI":"10.1042\/BCJ20230027","article-title":"Key allosteric and active site residues of sars-cov-2 3clpro are promising drug targets","author":"Al Adem","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107821_bib79","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0022-2836(74)90188-0","article-title":"A\u00a0thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study","volume":"86","author":"Privalov","year":"1974","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107821_bib80","series-title":"Emerging Variants of Sars-Cov-2 and Novel Therapeutics against Coronavirus (Covid-19)","author":"Aleem","year":"2023"},{"key":"10.1016\/j.jbc.2024.107821_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates sars-cov-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107821_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbc.2024.107821_bib83","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J.\u00a0Mol. Graphics Model."},{"key":"10.1016\/j.jbc.2024.107821_bib84","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/ct700119m","article-title":"Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms","volume":"3","author":"Shao","year":"2007","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jbc.2024.107821_bib85","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"Ptraj and cpptraj: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J.\u00a0Chem. Theory Comput."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824023238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824023238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:51:29Z","timestamp":1732809089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824023238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0021925824023238"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107821","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.16.540953","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107821"}}